We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
American medical device firm Realeve has secured a multimillion-dollar grant to fund a research initiative involving its Pulsante micro-neuromodulation system for post-stroke recovery. The study is slated to
Riverside University Health System, a US-based healthcare system, will implement FloPatch, a point-of-care ultrasound assessment tool developed by Canadian medical device company Flosonics Medical for monitoring blood flow
Hologic Inc. (Nasdaq: HOLX) and Bayer announced an international partnership to deliver contrast-enhanced mammography (CEM) solutions to improve the detection of breast cancer for women in multiple countries
Guardant Health, an American precision oncology company, has announced the closure of its minimum residual disease (MRD) study dubbed COBRA to new enrollees. The decision was based on
Boston Scientific said that the FARAPULSE Pulsed Field Ablation (PFA) System has met the primary efficacy and safety endpoints in the ADVENT study in patients with paroxysmal, or
Blackford, an imaging artificial intelligence (AI) platform and solutions provider, has forged an echocardiography AI partnership with Ligence Medical AI Solutions, a medical device company specialising in ultrasound
Aetion, the global leader in real-world evidence (RWE) technology and analytics, is pleased to announce that ‘A Screening Tool to Evaluate whether Using Real-world Data to Support an
HDL Therapeutics, a commercial-stage biotech company, is set to go public through a merger with Swiftmerge Acquisition, a special purpose acquisition company (SPAC), in a deal that values
Nasdaq-listed ReWalk Robotics has wrapped up the previously announced $19m acquisition of mobility enhancement products developer AlterG. Established in 2005, AlterG creates, produces, and sells Anti-Gravity systems. These
Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on commercializing a daily disposable wearable glucose sensor and supporting personalized digital coaching programs, announces that it has